Modelling of the blood–brain barrier in drug discovery and development
2007 · Nature Reviews Drug Discovery · 596 citations
https://doi.org/10.1038/nrd2368
M
Maxime Culot
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
67
Papers
3.2K
Citations
28
h-index
38
i10-index
Maxime Culot is an academic researcher from Université d'Artois. The author has contributed to research in topics: Barrier Structure and Function Studies & Drug Transport and Resistance Mechanisms & Neuroscience and Neuropharmacology Research. The author has an h-index of 28, co-authored 57 publications.
ORCID: 0000-0001-7452-0867Papers by this author
worksA Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells
2014 · PLoS ONE · 357 citations
https://doi.org/10.1371/journal.pone.0099733
Advancing brain barriers RNA sequencing: guidelines from experimental design to publication
2020 · Fluids and Barriers of the CNS · 27 citations
https://doi.org/10.1186/s12987-020-00207-2
An in vitro strategy using multiple human induced pluripotent stem cell-derived models to assess the toxicity of chemicals: A case study on paraquat
2022 · Toxicology in Vitro · 20 citations
https://doi.org/10.1016/j.tiv.2022.105333
Minimum information for studies of extracellular vesicles (MISEV) as toolbox for rigorous, reproducible and homogeneous studies on extracellular vesicles
2025 · Toxicology in Vitro · 20 citations
https://doi.org/10.1016/j.tiv.2025.106049
A Miniaturized Pump Out Method for Characterizing Molecule Interaction with ABC Transporters
2019 · International Journal of Molecular Sciences · 15 citations
https://doi.org/10.3390/ijms20225529
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat